Technical Analysis for BHC - Bausch Health Companies Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Up 3 Days in a Row | Strength | 0.00% | |
Crossed Above 20 DMA | Bullish | 6.30% | |
MACD Bullish Signal Line Cross | Bullish | 6.30% | |
Expansion Breakout | Bullish Swing Setup | 6.30% | |
Pocket Pivot | Bullish Swing Setup | 6.30% | |
Volume Surge | Other | 6.30% |
Alert | Time |
---|---|
Up 5% | about 18 hours ago |
Possible Pocket Pivot | about 19 hours ago |
60 Minute Opening Range Breakout | about 22 hours ago |
Up 3% | about 22 hours ago |
Up 1 ATR | about 22 hours ago |
Get a Trading Assistant
- Earnings date: 10/30/2024
Bausch Health Companies Inc. Description
Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Biotechnology Life Sciences Organ Systems Laser Eye Pharmaceutical Products Gastrointestinal Medical Device S&P/Tsx 60 Index Health Products Dermatology Psoriasis Specialty Drugs Ulcerative Colitis Gastroenterology Ulcer Atopic Dermatitis Colitis Acne Dermatitis Contact Lens Diarrhea Irritable Bowel Syndrome Generic Pharmaceutical Wrinkle Generic Pharmaceuticals Hair Removal Over The Counter Products Actinic Keratosis Keratosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 11.46 |
52 Week Low | 3.96 |
Average Volume | 2,307,415 |
200-Day Moving Average | 7.66 |
50-Day Moving Average | 7.55 |
20-Day Moving Average | 8.29 |
10-Day Moving Average | 8.40 |
Average True Range | 0.32 |
RSI (14) | 81.20 |
ADX | 33.61 |
+DI | 48.05 |
-DI | 10.63 |
Chandelier Exit (Long, 3 ATRs) | 8.85 |
Chandelier Exit (Short, 3 ATRs) | 8.80 |
Upper Bollinger Bands | 9.15 |
Lower Bollinger Band | 7.43 |
Percent B (%b) | 1.37 |
BandWidth | 20.71 |
MACD Line | 0.34 |
MACD Signal Line | 0.25 |
MACD Histogram | 0.0832 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 10.64 | ||||
Resistance 3 (R3) | 10.55 | 10.17 | 10.49 | ||
Resistance 2 (R2) | 10.17 | 9.96 | 10.22 | 10.44 | |
Resistance 1 (R1) | 9.98 | 9.82 | 10.08 | 10.07 | 10.40 |
Pivot Point | 9.60 | 9.60 | 9.65 | 9.65 | 9.60 |
Support 1 (S1) | 9.41 | 9.39 | 9.51 | 9.50 | 9.16 |
Support 2 (S2) | 9.03 | 9.25 | 9.08 | 9.12 | |
Support 3 (S3) | 8.84 | 9.03 | 9.07 | ||
Support 4 (S4) | 8.93 |